ONELAB Orchestrating next-generation mobile modular laboratories for pandemic monitoring preparedness
- Coordinator
- Stichting Amsterdam Umc, Netherlands
- Runs
- 1 October 2022 to 30 September 2025
- Status
- Running
- EU funding
- €3.7m
- Total cost
- €4.4m
- Partners
- 22 organisations in 10 countries
- Type
- Innovation Action
- Grant agreement
- 101073924
What the project is doing
In the project's own words, from its summary on CORDIS.
Expert opinion from across the world recommends, & calls for, modular laboratory systems to be made available for disease monitoring missions. The WHO calls these, “Rapid Response Mobile Laboratories” (RRML). ONELAB will develop modular RRML for rapid, flexible, scalable, multi-scenario deployments into the widest range of possible settings. These next-generation facilities will support next-generation measurement-technologies/methodologies and, through satellite communications, form wide-area GIS enabled laboratory information systems.
Thus, simultaneously providing point-of-need disease detection, along with high-level situational awareness. ONELAB will also develop advanced measurement systems for a staged disease detection response. Exploiting a panel of acute viral infection biomarkers enables early detection of disease during its asymptomatic incubation. Using this at the outbreak of disease, when much is still undefined, supports effective immediate & targeted public health interventions.
Additionally, using proven methodologies developed in response to COVID 19, ONELAB will develop & demonstrate a workflow for semi-autonomous disease specific biomarker discovery. This application & delivery of agile science enhances the capability & capacity of current disease testing-strategies substantiallyRRMLs are only as good as the skilled teams who operate them. So, ONELAB builds world-wide networks & partnerships of experienced experts to: define contextually-aligned best practice; develop a consensus-driven concepts of operation; and, disseminate this though a pandemic testing playbook.
We will develop capability & capacity with training & networking-events that continue beyond the project. Finally, community mass-testing requires engagement & acceptance from all citizens, which is why we will engage with the public, & produce a citizen’s guide to mass community testing, supported by educational outreach resources.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Coordinator |
| Johanniter Osterreich Ausbildung Und Forschung Gemeinnutzige GmbH | Wien | Austria | Participant |
| Solgenium Og | Linz | Austria | Participant |
| Universitaet Innsbruck | Innsbruck | Austria | Participant |
| Jurrisk | Herk De Stad | Belgium | Participant |
| Stad Hasselt | Hasselt | Belgium | Participant |
| Universiteit Gent | Gent | Belgium | Participant |
| Ianus Technologies Ltd | Larnaca | Cyprus | Participant |
| University of Cyprus | Nicosia | Cyprus | Participant |
| Bayerisches Rotes Kreuz | Munchen | Germany | Participant |
| G.a.s. Gesellschaft Fur Analytischesensorsysteme M.b.h. | Dortmund | Germany | Participant |
| Charokopeio Panepistimio | Athina | Greece | Participant |
| Panou Electronic Telecommunication Defence Equipment & Security Services Rendering Private Enterprise Commercial Handicraft SA | Nea Filothei Athina | Greece | Participant |
| Perifereia Dytiki Ellada | Patras | Greece | Participant |
| Telesto Technologies Pliroforikis Kai Epikoinonion Epe | Athina | Greece | Participant |
| Magyar Voroskereszt | Budapest | Hungary | Participant |
| Pecsi Tudomanyegyetem - University of Pecs | Pecs | Hungary | Participant |
| Istituto Di Sociologia Internazionale Di Gorizia | Gorizia | Italy | Participant |
| Saitama Medical University Educational Corporation | Saitama | Japan | Participant |
| Bioxhale Ltd | Leicester | United Kingdom | Associatedpartner |
| Imspex Diagnostics Limited | Abercynon | United Kingdom | Associatedpartner |
| Roboscientific Limited | Ely | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI